Literature DB >> 6327341

Cyclic nucleotide content and phosphodiesterase activity in the rds mouse (020/A) retina.

S Sanyal, R Fletcher, Y P Liu, G Aguirre, G Chader.   

Abstract

Cyclic nucleotide metabolism was examined in the retina and in the retinal pigment epithelium (RPE)-choroid complex of the rds mouse (020/A), a mutant in which discrete photoreceptor outer segment disc structures fail to develop. In retinas of both rds and control (Balb/c) mice, cyclic AMP levels peak at 10-15 days (20-25 pmol mg-1 protein). The level drops to about 10 pmol mg-1 at about one month in normal retinas but remains high in affected retinas. Cyclic GMP levels increase five-fold in Balb/c retinas as ROS develop whereas, in affected retinas, the levels remain constant and low (about 5 pmol mg-1). In RPE-choroid, cyclic nucleotide levels are similar in control and affected mice. Cyclic AMP phosphodiesterase (PDE) activity is somewhat higher in affected than in control retinas; conversely, cyclic GMP-PDE is lower. Both cyclic AMP-PDE and cyclic GMP-PDE activities are different in normal and affected RPE-choroid. Thus, although the rds (020/A) mouse belongs to the early-onset photoreceptor dysplasia group of hereditary retinal degenerations on a morphological basis, it does not exhibit high retinal cyclic GMP levels and thus appears to be distinct from other animals exhibiting early postnatal photoreceptor dysfunction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327341     DOI: 10.1016/0014-4835(84)90163-5

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  5 in total

1.  Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.

Authors:  R M H Diederen; E C La Heij; M Markerink-van Ittersum; A Kijlstra; F Hendrikse; J de Vente
Journal:  Br J Ophthalmol       Date:  2006-08-30       Impact factor: 4.638

2.  Neogenin neutralization prevents photoreceptor loss in inherited retinal degeneration.

Authors:  Jason Charish; Alireza P Shabanzadeh; Danian Chen; Patrick Mehlen; Santhosh Sethuramanujam; Hidekiyo Harada; Vera L Bonilha; Gautam Awatramani; Rod Bremner; Philippe P Monnier
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

3.  Screening for mouse retinal degenerations. II. Molossinus MOLC and MOLD strains.

Authors:  J V Winston; J R Heckenlively; T H Roderick
Journal:  Doc Ophthalmol       Date:  1989-03       Impact factor: 2.379

4.  Screening for mouse retinal degenerations. I. Correlation of indirect ophthalmoscopy, electroretinograms, and histology.

Authors:  J R Heckenlively; J V Winston; T H Roderick
Journal:  Doc Ophthalmol       Date:  1989-03       Impact factor: 2.379

Review 5.  The role of cGMP-signalling and calcium-signalling in photoreceptor cell death: perspectives for therapy development.

Authors:  Soumyaparna Das; Yiyi Chen; Jie Yan; Gustav Christensen; Soumaya Belhadj; Arianna Tolone; François Paquet-Durand
Journal:  Pflugers Arch       Date:  2021-04-16       Impact factor: 3.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.